![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/70 | |
A61K 39/09 |
(11) | Number of the document | 2917351 |
(13) | Kind of document | T |
(96) | European patent application number | 13788753.5 |
Date of filing the European patent application | 2013-11-07 | |
(97) | Date of publication of the European application | 2015-09-16 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/073266 |
Date | 2013-11-07 |
(87) | Number | WO 2014/072405 |
Date | 2014-05-15 |
(30) | Number | Date | Country code |
201261723408 P | 2012-11-07 | US |
(72) |
WACKER, Michael, CH
KOWARIK, Michael, CH
WETTER, Michael, CH
FARIDMOAYER, Amirreza, CH
|
(73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
(54) | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |
PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |